NCT03791333 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Baker SP, O'Neill B, Haddon W Jr, Long WB
The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974 Mar;14(3):187-96.
Jennett B
The Glasgow Coma Scale: History and current practice. Trauma, 2002, 4(2):91-103.
Kirkpatrick JR, Youmans RL
Trauma index. An aide in the evaluation of injury victims. J Trauma. 1971 Aug;11(8):711-4.
Koehler JJ, Baer LJ, Malafa SA, Meindertsma MS, Navitskas NR, Huizenga JE
Prehospital Index: a scoring system for field triage of trauma victims. Ann Emerg Med. 1986 Feb;15(2):178-82.

A Multi-center Clinical Study on the Status of Trauma Evaluating Ability in Patients With Multiple Trauma

Clinical trial NCT03791333 - References